MedDataX Logo

Children With ADHD Symptoms: Comorbid Conditions, Cognitive and Social Performance

NCT ID: NCT01252446

Last Updated: 2010-12-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

187 participants

Study Classification

OBSERVATIONAL

Study Start Date

2008-09-30

Study Completion Date

2010-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This article reviews social-demographic variables (SDV) including interpersonal and academic and social performance in families and comorbid conditions(CC) which are the most associated with Attention-Deficit/Hyperactivity Disorder (ADHD)in the sample that has been confirmed diagnosis of ADHD and sample with the same symptoms but not confirmed diagnosis of ADHD.

There are no reports of this kind in the Norwegian population with ADHD.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

ADHD is one of the largest diagnostic groups in psychiatric health care for children and adolescents in Norway. In the guidelines laid out by the central authorities, ADHD is to be prioritized. As can be seen by the attention this topic is given in the media, good diagnostics and treatment for this group are important for society as well as the individuals who suffer from this. Early diagnosis, proper organization and appropriate treatment have a positive effect on the self-esteem and development of the person diagnosed as well as probable socio-economic benefits for society.

ADHD population shows significant pattern in socio-demographic relations and comorbidity according to the population that is referred to community Mental Health Clinic due another types of psychiatric conditions.

In terms of comorbid states ODD and OCD are most associated with ADHD . The study indicates prevalence of ADHD children (74%) who met criteria for ADHD, Combined Type (ADHD-C, both inattention and hyperactivity-impulsivity symptoms) and the existence of generally low IQ measures with mean value of 85 points. In terms of comorbid states generally were found in almost whole ADHD group (93 %) compared to half of the non-ADHD group. Disruptive Behaviour Disorder, Anxiety /Stress related disorder and Encopresis /Enuresis shows significant difference between the groups. Other comorbid conditions show no significant differences. Social dysfunctions were found in four of five children.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Comorbid Conditions Social-demographic Profiles

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

ICD 10 Attention-Deficit-Hyperactivity-Disorder (ADHD) Comorbidity Social-demographic profile

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

ADHD

The sample of 187 children and adolescent in the age of 6 to 17 years referred to the Child and Adolescent Clinic, Haugesund, Norway during the period of one year and diagnosed in ICD 10 system as ADHD.

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* clinical symptoms related on diagnosis of ADHD
* age from 6-17 years

Exclusion Criteria

* retardation
* somatic disorder
Minimum Eligible Age

6 Years

Maximum Eligible Age

17 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Helse Fonna

OTHER

Sponsor Role collaborator

University of Bergen

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

University of Bergen, Child and Adolescent Clinic Helse Fonna

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Irene Elgen, m.d.PhD

Role: STUDY_CHAIR

University in Bergen

Nezla Duric, M.D.

Role: PRINCIPAL_INVESTIGATOR

University in Bergen

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Child and Adolescent Psychiatry Clinic Helse Fonna Haugesund

Haugesund, Rogaland, Norway

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Norway

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Nezla Duric, M:D:

Role: CONTACT

Phone: 004790544231

Email: [email protected]

Irene Elgen, M.D.PhD.

Role: CONTACT

Phone: 0047

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Tove Vågen, CCORDINATOR

Role: primary

Nezla Duric, M.D.

Role: backup

References

Explore related publications, articles, or registry entries linked to this study.

Jensen PS, Hinshaw SP, Kraemer HC, Lenora N, Newcorn JH, Abikoff HB, March JS, Arnold LE, Cantwell DP, Conners CK, Elliott GR, Greenhill LL, Hechtman L, Hoza B, Pelham WE, Severe JB, Swanson JM, Wells KC, Wigal T, Vitiello B. ADHD comorbidity findings from the MTA study: comparing comorbid subgroups. J Am Acad Child Adolesc Psychiatry. 2001 Feb;40(2):147-58. doi: 10.1097/00004583-200102000-00009.

Reference Type BACKGROUND
PMID: 11211363 (View on PubMed)

Pliszka SR. Psychiatric comorbidities in children with attention deficit hyperactivity disorder: implications for management. Paediatr Drugs. 2003;5(11):741-50. doi: 10.2165/00148581-200305110-00003.

Reference Type BACKGROUND
PMID: 14580223 (View on PubMed)

da Silva MA, Louza MR, Vallada HP. Attention deficit hyperactivity disorder (ADHD) in adults: social-demographic profile from a university hospital ADHD outpatient unit in Sao Paulo, Brazil. Arq Neuropsiquiatr. 2006 Sep;64(3A):563-7. doi: 10.1590/s0004-282x2006000400004.

Reference Type BACKGROUND
PMID: 17119791 (View on PubMed)

Duric NS, Assmus J, Gundersen D, Elgen IB. Neurofeedback for the treatment of children and adolescents with ADHD: a randomized and controlled clinical trial using parental reports. BMC Psychiatry. 2012 Aug 10;12:107. doi: 10.1186/1471-244X-12-107.

Reference Type DERIVED
PMID: 22877086 (View on PubMed)

Related Links

Access external resources that provide additional context or updates about the study.

http://www.ncbi.nlm.nih.gov/pubmed/17667478

MTA study

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

219.04(REK)

Identifier Type: -

Identifier Source: secondary_id

219.04 REK

Identifier Type: -

Identifier Source: org_study_id